Jump to:
Authorities in the field, including internationally renowned pulmonologist Gerard J. Criner, MD, board member for the Global Initiative for Chronic Obstructive Lung Disease (GOLD), an author of the GOLD guidelines, and Director of the Temple Lung Center in Philadelphia, PA presented at the following sessions:
1:00 – 4:00 pm PT
Innovations of the year award: Temple University Hospital
TextBytes for Smarter Practice: Revolutionizing Tobacco Use Disorder Treatment Education for Physicians
Zehra Dhanani, Veena Dronamraju, Jamie Garfield
TIME: 9:15 AM – 11:15 AM
New and Old Definitions of Pre-capillary and Severe Pulmonary Hypertension: Predicting Mortality in Sarcoidosis Associated Pulmonary Hypertension
T. Russeth, O. Schanz, P. Rali, G. J. Criner, S. Gayen
TIME: 9:15 AM – 11:15 AM
Impact of Biologics on Exacerbation Burden and Pulmonary Function Tests in Patients With COPD and ACOS: A Real-world, Single-center Review
S. Dachert, T. A. Ho, I. Albaba, S. Ansari, N. Provenzano, J. Halicki, G. J. Criner
Efficacy of Mepolizumab in Patients With COPD and an Eosinophilic Phenotype With Chronic Bronchitis - A Post Hoc Analysis of the METREX & METREO Phase 3 Studies
G. J. Criner, N. A. Hanania, F. Maltais, F. Martinez, M. Bafadhel, H. Watz, D. Singh, R. Chan, S. Kolterer, B. Mayer
Bronchoscopic Lung Volume Reduction With Zephyr Endobronchial Valves Improves Lung Function and Symptoms in Chronic Obstructive Pulmonary Disease Patients With Alpha-1 Antitrypsin Deficiency
M. Nicholson, G. J. Criner
Bronchial Rheoplasty Reduces Mucus Plugging in Patients with Chronic Bronchitis
V. Kim, W. S. Krimsky
TIME: 11:30 AM – 1:15 PM
Large Pericardial Cyst in a Lung Transplant Patient
K. H. Patel, J. Halicki, S. Dachert, A. Mamary
TIME: 11:30 AM – 1:15 PM
Post-operative Outcomes in Patients With Pulmonary Sarcoidosis in Relation to Lung Explant Pathology
I. Tsai, J. Kim, M. Zheng, A. Aneja, M. Kumaran, A. L. Johnson Whiting, R. Criner, B. H. Lashari, F. Anjum, N. Marchetti, K. V. Shenoy, A. J. Mamary, F. C. Cordova, N. Shigemura, G. J. Criner, R. Gupta
How the 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines Affect Our Understanding of Mortality in Non-IPF ILD
I. Tsai, O. Schanz, P. Rali, G. J. Criner, S. Gayen
TIME: 11:30 AM – 1:15 PM
Impact of COPD Exacerbations and CT-Emphysema on Presence of Pleural Adhesions in Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS) Lung Resection
A. Gulzar, N. Marchetti, C. Bakhos, G. J. Criner
TIME: 11:30 AM – 1:15 PM
Left-Side Mystery: Unusual Cause of Chest Fluid - A Case Report
Z. Dhanani, G. J. Criner
TIME: 11:30 AM – 1:15 PM
A Rare Case of a Bronchocutaneous Fistula After Xylazine Use
J. Kim, I. Tsai, M. Kumaran, R. Gupta
TIME: 11:30 AM – 1:15 PM
Prognostic Value of Tricuspid Annular Plan Systolic Excursion/Right Ventricular Systolic Pressure Ratio in Acute Pulmonary Embolism
K. Santerian, K. U. Lio, B. Rivera-Lebron, S. Brosnahan, P. Rali
Predictors of Residual Pulmonary Vascular Obstruction After Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality
T. A. Ho, J. M. Pescatore, K. U. Lio, G. J. Criner, P. Rali, S. Gayen
S. Ansari, A. B. Karanam, S. Gayen, P. Rali, G. J. Criner
TIME: 11:30 AM – 1:15 PM
Impaired DNA Damage Repair in Alveolar Type II Cells in Idiopathic Pulmonary Fibrosis
K. Bahmed, C. Lin, L. Karim, S. Bolla, N. Marchetti, G. J. Criner, B. Kosmider
TIME: 11:30 AM – 1:15 PM
Impact of Revised ESC Pulmonary Hypertension Criteria on Lung Transplantation Waitlist Outcomes in Idiopathic Pulmonary Fibrosis Patients
Z. Dhanani, M. Nicholson, S. Gayen
TIME: 11:30 AM – 12:30 PM
Treatment of sarcoidosis remains challenging, but the field has been evolving faster recently with new agents in development. This session focuses on individualization of therapy, discusses the general principles in use of different drugs in clinical practice and an insight into the new agents in pipeline for sarcoidosis.
Rohit Gupta, MD, MBBS
TIME: 2:15 PM – 4:15 PM
Distinct Neutrophil Phenotypes in Sepsis Patients and Associations With Disease Severity, Comorbidities, and Neutrophil Extracellular Traps (NETs)
S. Pettigrew, R. Prosniak, Q. Yang, J. Langston, E. Perez, H. Edelmann, N. Mansoor, N. Marchetti1, M. Kiani, L. Kilpatrick
TIME: 2:15 PM – 4:15 PM
Role of Fungal Colonization in the Development of Chronic Lung Allograft Dysfunction
Z. Dhanani, G. J. Criner, F. Anjum
TIME: 9:15 AM - 11:15 AM
Outcomes of Bronchoscopic Lung Volume Reduction in Patients With Static and Dynamic Hyperinflation
A. B. Karanam, M. Reeves, J. Thomas, G. J. Criner
TIME: 11:30 AM – 1:15 PM
Navigating Airway Challenges After Lung Transplantation
Z. Dhanani, G. J. Criner, F. Anjum
Preoperative Anemia as a Risk Factor for Post Operative Outcomes in Patients Undergoing Lung Transplant
J. Galvis, T. A. Ho, O. Schanz, T. Russeth, H. Zhao, J. Armstrong, J. Mamary
The Prevalence and Evaluation of Anemia in Lung Transplant Recipients: A Single Center Experience
T. A. Ho, J. Galvis, M. Goulet, T. Joshi, H. Zhao, J. Armstrong, A. J. Mamary
TIME: 11:30 AM – 1:15 PM
Pulmonary Vasodilator Therapy in Idiopathic Pulmonary Fibrosis Associated Pulmonary Hypertension
R. Strock, O. A. Schanz, P. Rali, G. J. Criner, S. Gayen
TIME: 11:30 AM – 1:15 PM
TIME: 11:30 AM – 1:15 PM
Impact of Biologics in Patients With COPD and ACOS: A Real-world, Single-center Review of Factors Associated With Greater Reduction in Exacerbation Frequency
S. Dachert, T. A. Ho, I. Albaba, S. Ansari, N. Provenzano, J. Halicki, G. J. Criner
Ensifentrine Added on to LABA/ICS Therapy Improved Lung Function and Reduced Exacerbations in Symptomatic Subjects With Moderate-to-Severe COPD
N. Marchetti, R. Kalhan, M. T. Dransfield, A. Anzueto, T. Rheault, D. Reyner, T. Bengtsson, K. Rickard
Targeted Lung Denervation in COPD: 2-year Follow-up of the Airflow-3 Open-label Treatment Cohort
G. J. Criner, F. C. Sciurba, D.-J. Slebos, S. P. Bhatt, C. Ghattas, B. Petkovich, J. De Cardenas, C. R. Lamb, R. D. Sue, P. L. Shah
TIME: 11:30 AM – 1:15 PM
Disparity in Pulmonary Embolism Outcomes Amongst Asians
A. Mittal, S. Li2, T. A. Ho, M. Yaqoob, P. Rali
TIME: 11:30 AM – 1:15 PM
Prognostic Limitations for Who Group 3 Pulmonary Hypertension Patients - A Retrospective Study
M. J. Bittner, J. M. Pescatore, S. E. Weaver, S. Gayen
Clinical Significance of Updated Pulmonary Hypertension Guidelines on Combined Pulmonary Fibrosis and Emphysema (CPFE)
J. Moore, P. Rali, S. Gayen
New European Society of Cardiology Definition of Severe Pulmonary Hypertension Predicts Mortality in Patients With Idiopathic Pulmonary Fibrosis
A. Kurtzman, P. Rali, G. J. Criner, S. Gayen
Pulmonary Vasodilatory Therapy in Patients With Chronic Obstructive Pulmonary Disease-mediated Pulmonary Hypertension
A. Chung, P. Rali, G. J. Criner, S. Gayen
ILD/CPFE With Severe WHO Group III PH Patients Referred to Transplant Center for Evaluation: An Observational Study
J. M. Pescatore, M. Bitter, S. E. Weaver
Effect of Updated European Society of Cardiology Pulmonary Hypertension Diagnostic Criteria on Lung Transplantation Waitlist Outcomes in Hypersensitivity Pneumonitis Patients Listed for Lung Transplantation
M. Nicholson, Z. Dhanani, S. Gayen
Effect of Pulmonary Vasodilator Therapy on Survival and Functional Outcomes in Patient With Combined Pulmonary Fibrosis and Emphysema and Pulmonary Hypertension
O. A. Schanz, I. Tsai, J. Moore, T. Joshi, A. Chung, R. Strock, A. Kurtzman, T. Russeth, K. Johnson, J. Galvis, S. Gayen
TIME: 11:30 AM – 1:15 PM
AI-driven PE Detection and RV/LV Ratio Measurement: A Preliminary Validation Study
Z. Dhanani, K. U. Lio, T. Joshi, P. Rali
Real World Assessment of Artificial Intelligence for Pulmonary Embolism Detection and Risk Stratification
S. Pettigrew, J. Nathan, K. Maruti, G. Cohen, G. J. Criner, P. Rali
TIME: 11:30 AM – 1:15 PM
S100A8-MCM3 Axis in Alveolar Type II Cells in Emphysema
K. Bahmed, C. Lin, S. Bolla, N. Marchetti, G. J. Criner, B. Kosmider
TIME: 11:30 AM – 1:15 PM
Change in Pulmonary Artery: Aorta Ratio (PA:A) in Patients Undergoing Bronchoscopic Lung Volume Reduction Surgery (BLVR) Vs Lung Volume Reduction Surgery (LVRS)
S. Ansari, S. Dachert, S. Gayen, J. Thomas, H. Zhao, C. Dass, G. J. Criner
Predictors of Dynamic Hyperinflation in Advanced Chronic Obstructive Pulmonary Disease
A. B. Karanam, J. Thomas, G. J. Criner
TIME: 9:15 AM – 11:15 AM
AI Assisted Lung Texture Analysis Association With Lung Rads Score in an Urban Comprehensive Lung Cancer Screening Program for Lung Nodules Coupled With Detection of Comorbid Conditions: Temple Healthy Chest Initiative (THCI)
S. Dachert, M. A. Seigo, O. Ahearn, G. J. Criner
Relationship Between AI Assisted Lung Texture Analysis and Pulmonary Function Testing in an Urban Comprehensive Lung Cancer Screening Program for Lung Nodules Coupled With Detection of Comorbid Conditions: Temple Healthy Chest Initiative (THCI)
S. Dachert, M. A. Seigo, O. Ahearn, G. J. Criner
TIME: 11:30 AM – 1:15 PM
Safety Profile of Astegolimab, An Anti-ST2 Antibody: A Systematic Review
S. G. Kelsen, G. Alvaro, L. Millette, D. Mohan, X. Yang, C. E. Brightling
TIME: 11:30 AM – 1:15 PM
Near Complete Disruption of the Right Mainstem Bronchus After Blunt Thoracic Trauma
D. Potarazu, S. B. Peer, P. Ferrada
TIME: 11:30 AM – 1:15 PM
Prevalence of Spirometric Obstruction and Undiagnosed COPD in Lung Cancer Screening Cohorts: A Systematic Review and Meta-analysis
S. Dachert, M. A. Seigo, M. E. Zulty, G. J. Criner
TIME: 11:30 AM – 1:15 PM
New 2022 ESC/ERS Severe Pulmonary Hypertension Definition Better Predicts Mortality in Patients With COPD
T. Joshi, S. Olivia2, G. J. Criner2, P. Rali2, S. Gayen
Pulmonary Comorbidities, Respiratory Symptoms, and Spirometry in a Real-world, Urban Lung Cancer Screening Program
M. A. Seigo, S. Dachert, A. B. Karanam, G. J. Criner
TIME: 11:30 AM – 1:15 PM
Primary Pulmonary Biphasic Synovial Sarcoma - A Case Report
B. Y. Graham, A. Padmanabhan
TIME: 2:15 PM – 3:45 PM
Chairs: Rohit Gupta, MD, MBBS and Jin Sun Kim, MD
Discussion on current understanding of (and knowledge gaps in) disease mechanisms, recent advances in management and ongoing/ future research endeavors on pulmonary sarcoidosis and APS.
Dr. Gupta will present on Lung Transplantation and Holistic Care in APS.
TIME: 2:15 PM – 4:15 PM
Trends and Racial Disparities in Pulmonary Embolism Admissions From 2017 to 2023
A. Mittal, S. Li, T. A. Ho, P. Rali
TIME: 2:15 PM – 4:15 PM
Pulmonary Embolism With Trauma-Associated Thrombotic Microangiopathy
J. Ayyoub, M. A. Seigo, P. Rali, A. Ajmeri
TIME: 2:15 PM – 4:15 PM
Neoadjuvant Soft Tissue Ablation Utilizing Aliya™ Pulsed Electric Fields With Systemic Therapy in Early-stage Resectable Non-small Cell Lung Cancer (NSCLC) - VIGOR Study
J. Reisenauer, D. Dibardino, G. J. Criner, M. Callstrom, S. Hunt, J. Panero, W. S. Krimsky
TIME: 8:15 AM – 10:15 AM
Plastic Bronchitis as a Complication of Primary Graft Dysfunction After Single Lung Transplantation
M. A. Seigo, J. Ayyoub, J. M. Pescatore, S. Dachert, G. D'Alonzo
TIME: 11:00 AM – 1:00 PM
Thrombus In Situ Unveiled: Distinguishing Pulmonary Artery Thrombosis From Pulmonary Embolism
Z. Dhanani, C. Edward, B. H. Lashari, M. Kumaran
TIME: 11:00 AM – 1:00 PM
Applying the New Definition of Pulmonary Hypertension to Patients With Idiopathic Pulmonary Fibrosis on the Transplant Waitlist, A Registry Review
M. E. Zulty, G. J. Criner, S. Gayen
TIME: 11:00 AM – 1:00 PM
A Rare Case of Primary Lung Synovial Sarcoma With Squamous Differentiation and a Novel FOXL2 Mutation in an Older Patient
A. B. Karanam, M. E. Zulty, G. E. D Alonzo, J. Friedberg, M. F. Gonzalez